Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Pilot Study of Pivanex, a Histone Deacetylase Inhibitor, in Patients With Chronic Lymphocytic Leukemia

NCT00083473 is registered in ClinicalTrials.gov with Titan Pharmaceuticals as lead sponsor.

NCT NCT00083473
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00083473 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Pilot Study of Pivanex, a Histone Deacetylase Inhibitor, in Patients With Chronic Lymphocytic Leukemia
Lead sponsor
Titan Pharmaceuticals
Phase
Phase 2
Overall status
Terminated
Start date
May 31, 2004
Completion date
April 30, 2005
Enrollment
28
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

leukemia, lymphocytic, chronic, lymphoma, small lymphocytic